Volume 3, Issue 12, Page 8 (December 2007)
8 of 29
PREVIEW
FULL TEXT
FULL-TEXT PDF (107 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
PHILADELPHIA — Making the switch from an enzyme-inducing to a noninducing antiepileptic drug led to a significant fall in serum levels of cholesterol and C-reactive protein in a review of 38 patients at one center.
PII: S1553-3212(08)70008-6
doi:10.1016/S1553-3212(08)70008-6
© 2007 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.